SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bio-Thera Says China Approves BAT2306 Secukinumab Biosimilar

Bio-Thera Solutions announced that China’s NMPA approved BAT2306, which it describes as the first secukinumab biosimilar approved in China.

Related stories